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 Abstract: 
BACKGROUND: Maspin, a 42-kDa protein, belongs to the serpin family of protease 
inhibitors and is known to have tumor-suppressor function. In the current study, we 
investigated the interrelationship between clinicopathological findings and maspin 
expression in oral squamous cell carcinoma (OSCC). 
METHODS: Using immunohistochemical techniques to examine the expression levels 
of maspin in OSCC, maspin expression in OSCC was detected in 46 (64.8%) of 71 
cases. We also compared the clinicopathological features of OSCC cases with maspin 
expression levels. Moreover, we examined expression of maspin in eight cell lines 
derived from OSCC using Reverse-Transcription PCR (RT-PCR) and western blotting. 
RESULTS: There was a significant correlation between decreased maspin expression 
and T-category (p < 0.01), lymph metastasis (p < 0.0001), and mode of invasion (p < 
0.0001). Patients with positive maspin expression had a significantly better prognosis (p 
< 0.001). Lower expression of maspin was also seen in cell lines derived from grade 4D, 
which shows stronger invasive potential than other grades of OSCC. 
CONCLUSION: Maspin may be a useful marker to identify the potential for 
progression in OSCC. 
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 Introduction 
Maspin, which was originally identified in normal human breast epithelial and 
myoepithelial cells, is a 42-kDa cytoplasmic protein that belongs to the serpin family of 
protease inhibitors (1, 2). The gene has subsequently been localized to epithelial cells in 
a variety of tissues, including oral squamous epithelium, and its protein specifically 
functions as a protease inhibitor by blocking tissue plasminogen activator (PA) in vitro 
(3-5). It has been proposed that tumor cells produce PA in order to facilitate cellular 
invasion and migration (6, 7). These reports suggest that maspin, which inhibits tissue 
PA, is a tumor-suppressive factor. A correlation between the absence of maspin 
expression and poor prognosis has been reported for several tissues, including colon, 
uterus, breast, prostate, skin and thyroid (2-6, 8, 9). 
The TNM classification is a good system for describing the condition of cancer 
patients. However this system cannot predict the prognosis of individual patients and 
cannot describe the biological characteristics of tumor cells. It is therefore important to 
look for new objective prognosis factors that add information about the biological 
characteristics of tumors. It is believed that invasion and metastasis are the most crucial 
characteristics of malignant tumors. Thus, mode of invasion is used as a 
histopathological classification category in oral SSC (OSCC), as described by 
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 Yamamoto et al., and this classification is frequently used to predict progression, 
metastasis and prognosis (10-15). To provide proper treatment, it is also important to 
examine the characteristics of cancer cells at the invasive front of OSCC. We thus 
immunohistochemically examined the expression of maspin in vivo and compared 
maspin expression in cell lines derived from invasive OSCC in vitro with regard to 
mode of invasion of OSCC. 
 
Materials and methods 
Patients  
Seventy-one biopsy specimens of primary OSCC were obtained from patients 
undergoing surgical resection at the Department of Oral and Maxillofacial Surgery of 
Kanazawa University Hospital between 1989 and 2006. The patients (38 males, 33 
females) ranged in age from 27 to 92 years (mean age, 64 years). 
 
Staining methods 
Biopsy specimens were fixed in periodate-lysine-paraformaldehyde solution or 10% 
formalin solution, and were then embedded in paraffin to prepare serial sections (4 μm). 
Hematoxylin and eosin (H-E) staining was used for histological examination. 
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 Immunohistochemical staining was performed by the labeled streptavidin-biotin 
(LSAB) method after deparaffinization and rehydration. Endogenous peroxidase was 
blocked using 0.3% hydrogen peroxide for 30 min. Sections were washed with PBS. 
Excess blocking solution was drained and the sections were incubated with primary 
antibody overnight at 4°C. Sections were reacted with primary antibody; anti-maspin 
monoclonal antibody (LAB VISION, Fremont CA, USA) 300-fold diluted with PBS at 
4°C for 24 h (9). Sections were then reacted with secondary antibody; biotin-labeled 
goat anti-mouse immunoglobulin polyclonal antibody (Dako Japan, Kyoto, Japan) at RT 
for 60 min. After reacting with peroxidase-conjugated streptavidin (Dako) for 60 min, 
sections were washed with PBS. Immunohistochemical reactions were developed in 
0.01% 3,3’-diaminobenzidine tetrahydrochloride. For nuclear staining, hematoxylin was 
used. A section of normal oral epithelium previously identified as having strong staining 
was used as a positive control with each batch. As a negative control, PBS treatment 
was used instead of maspin antibody. 
 
Cell culture and cell lines 
All cell lines were maintained at 37°C in a humidified incubator containing 5% CO2. 
OSCC cell lines HSC-2, HSC-4, OSC-20, OBC-01, OSC-19, OTC-04, HOC313 and 
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 TSU were maintained in minimal essential medium (MEM; Sigma-Aldrich, Ayrshire, 
UK) supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. Cell 
lines were derived from OSCC with the following grades of invasiveness, according to 
Yamamoto-Kohama criteria (11) (Table 1): HSC-2, HSC-4 and OSC-20 cells from 
grade 3, described as weakly invasive; OBC-01, OSC-19 and OTC-04 from grade 4C, 
described as mildly invasive; HOC313 and TSU from 4D, described as highly invasive. 
 
RNA extraction and reverse transcriptase-polymerase chain reaction (RT-PCR) 
RNA was extracted from cultured cells using an RNeasy kit (Qiagen, Hilden, 
Germany). A 1-μg sample in 10 μl RNase-free water was incubated for 5 min at 60°C 
and was then quickly chilled on ice for 5 min. RNA samples were reversed-transcribed 
into first-strand cDNA at 40°C for 40 min in RT solution from the RNeasy kit. The 
cDNA samples were amplified following addition of the PCR mixture solution from the 
RNeasy kit and the following primers (16-18): for maspin, 5’-CAG GCA CAA CAA 
AAC TCG AA-3’ (forward) and 5’-AAT CGG CAT CCA CAG AAA AG-3’ (reverse); 
for E-cadherin, 5’-AGC CAT GGG CCC TTG GAG-3’ (forward) and 5’-CCA GAG 
GCT CTG TCA CCT TC-3’; and for β-actin, 5’-GAA AAT CTG GCA CCA CAC 
CTT-3’ (forward) and 5’-TTG AAG GTA GTT TCG TGG AT-3’ (reverse). PCR was 
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 carried out under the following conditions: 3 min at 94°C, followed by cycles (32 for 
maspin, 30 for E-cadherin and 20 for β-actin) of 1 min at 94°C, 1 min at 58°C, and 1 
min at 72°C. All reactions were completed with a final incubation at 72°C for 10 min. 
The lengths of the amplified fragments for maspin, E-cadherin and β-actin were 104, 
653 and 592 bp, respectively. PCR products were detected by 3.0% agarose gel 
electrophoresis and staining with ethidium bromide. 
 
Western blot analysis 
Parent- and resistant-cells on 80% confluent plates were used as protein samples. 
Samples (25 μg) that were extracted from the whole cellular structure using M-PER 
Mammalian protein extraction reagent (Pierce, Rockford, IL, USA) were heated at 95°C 
for 5 min before 10% SDS-PAGE. After electrophoresis, samples ware transferred onto 
PVDF membranes (ATTO Co., Tokyo, Japan) and incubated for 1 h with 500-fold 
diluted polyclonal anti-rabbit antibody against maspin (BD Biosciences, San Jose, CA, 
USA) and 5000-fold diluted polyclonal anti-mouse antibody β-actin (Sigma, St. Louis, 
MO, USA), respectively. The membrane was washed three times with PBS and was 
then incubated for 1 h with 2000-fold diluted horseradish peroxidase-conjugated 
anti-mouse IgG (Amersham, Buckinghamshire, UK) to detect maspin and β-actin, 
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 respectively. Blots were revealed by enhanced chemiluminescent detection carried out 
according to the manufacturer’s instructions. 
 
Assessment of immunohistochemical staining of maspin proteins 
Expression of maspin in tumor cells was evaluated as present or absent. Only cases in 
which at least 50% of the tumor cells were immunoreactive were scored as positive. 
Evaluation was performed by an observer completely blinded to patient characteristics. 
Mann-Whitney’s U test was used to analyze the association between maspin expression 
and clinico-pathological factors, such as tumor site, differential type, T-category, lymph 
node metastasis and mode of invasion. Survival rates of maspin-positive and -negative 
patients were calculated by the Kaplan-Mayer method, and were examined for statistical 




Immunohistochemistry and evaluation 
The relationship between the clinico-pathological parameters and expression of 
maspin are summarized in Table 2. Maspin immunostaining was observed in cytoplasm, 
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 membrane and nuclear of tumor cells (Fig. 1). Immunohistochemical staining showed 
that 46 of the 71 specimens (64.8%) examined were positive for maspin. There was a 
significant negative correlation between maspin and mode of invasion (p < 0.0001); the 
number of maspin-positive cases was 1 (100%) for grade 1, 11 (100%) for grade 2, 16 
(80%) for grade 3, 8 (66.7%) for grade 4C, and 1 (10%) for grade 4D. 
Moreover, the number of maspin-positive cases was 18 (43.9%) with lymph node 
metastasis and 28 (93.3%) without lymph node metastasis. Therefore, maspin 
expression showed a negative correlation with lymph node metastasis (p < 0.0001). 
As shown in Figure 2, patients with high maspin expression had better survival rates 
than those with low levels of maspin expression (p < 0.001). 
 
Analysis of maspin mRNA and E-cadherin levels in OSCC cell lines by RT-PCR 
We further examined the levels of maspin and E-cadherin in these eight cell lines by 
RT-PCR. Expression of maspin was significantly lower in HOC313 and TSU cell lines 
(grade 4D) than in other cell lines (Fig. 3). 
 
Analysis of maspin protein levels in OSCC cell lines by western blotting 
Levels of maspin protein expression were examined by western blotting (Fig. 4). 
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 Expression of maspin protein was significantly lower in HOC313 and TSU cell lines 
(grade 4D) than in other cell lines. 
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 Discussion 
OSCC is characterized by a high degree of invasion into local tissues, as well as a 
high incidence of lymph node metastasis. However, there have been few reports 
regarding the possible association between expression of maspin and invasive potential 
in OSCC. In this study, maspin expression also showed a negative correlation with 
T-category, lymph node metastasis and mode of invasion. Xie et al. (19) and Yasumatsu 
et al. (20) reported that decreased maspin expression in OSCC is associated with an 
unfavorable clinical outcome due to invasion and lymph metastasis, which is supported 
by the results of this study. Moreover, Xu et al. (3) reported that maspin plays a role in 
disease progression from in situ to invasive carcinoma of the uterine cervix. On the 
other hand, Cho et al. (21) reported that maspin expression in early oral tongue cancer 
was not correlated with survival. Thus, we believe that expression of maspin weakens as 
the tumor enlarges and becomes more invasive. 
Ets-1 proteins constitute a family of transcription factors implicated in the regulation 
of several matrix-degrading proteinases, including maspin. Ets-1 has been reported to 
activate the expression of MMP-1,-3 and -9, as well as urokinase-type plasminogen 
activator (uPA) and maspin, via the Ets-1-binding sites in the promoters of these genes 
(22-24). Moreover, Ets-1 functions as an effector for EMT, and it enhances the 
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 malignancy of SCC cells through the regulation of proteolytic enzymes, including 
maspin in the course of EMT (23-25). In this study, cases and cell lines were derived 
from grade 4D, which shows EMT characteristics such as spindly shape and decreased 
expression of E-cadherin, and they expressed lower levels maspin than other invasion 
grades. Thus, EMT may be related to proteolytic enzymes, including maspin, and is 
correlated with invasion by regulating expression of Ets-1. 
Moreover, the adhesion protein E-cadherin plays an important role in homophilic 
cell-cell adhesion and is known as an invasion suppressor gene. It has been reported that 
expression of E-cadherin is down-regulated during the acquisition of metastatic 
potential during the late stages of epithelial tumor progression (26-28). In our study, 
maspin and E-cadherin were expressed at significantly lower levels in two cell lines 
established from grade 4D OSCC, compared with cell lines derived from other invasive 
grades. 
In conclusion, maspin may be a useful marker to identify the potential for 
progression of OSCC, as lower immunoreactivity is associated with larger tumor and 
greater invasive potential, particularly for grade 4D. It is necessary to clarify the 
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Table 1. Histological grading of mode of cancer invasion. 
Gradea
1. Well-defined borderline 
2. Cords, less marked borderline 
3. Groups of cells, no distinct borderline 
4. Diffuse invasion 
4C : Cord-like type 

























Parameter Positive no. (%) Negative no.(%) Total 
Tumor site    
   Tongue 23 (67.6) 11 (32.3) 34 
   Gingiva 9 (45.0) 11 (55.0) 20 
   Oral floor 7 (100) 0 (0) 7 
  Buccal 6 (75.0) 2 (25.0) 8 
   Others 1 (50.0) 1 (50.0) 2 
Differential type    
   Well 31 (70.5) 13 (29.5) 44 
   Moderately 10 (62.5) 6 (37.5) 16 
   Poorly 5 (45.5) 6 (54.5) 11 
T-category    
   T1 17 (89.5) 2 (10.5) 19 
   T2 19 (61.3) 12 (38.7) 31 
   T3 4 (75.0) 2 (25.0) 6 
   T4 6 (40.0) 9 (60.0) 15 
Lymph node metastasis    
   Positive 18 (43.9) 23 (56.1) 41*
   Negative 28 (93.3) 2 (6.7) 30*
Mode of invasion    
1 10 (100) 0 (0) 10*
2 11 (100) 0 (0) 11*
3 16 (80.0) 4 (20.0) 20*
4C 8 (66.7) 12 (33.3) 20*
4D 1 (10.0) 9 (90.0) 10*
    
Total 46 (64.8) 25 (35.2) 71 
 



